CIK 0001907108
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Lexeo Therapeutics, Inc.
Sign in to watch- Ticker
- LXEO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 854012572
- Phone
- +1 212-547-9879
- Business address
- 345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $18,214
- in 3 filings
Net −$18,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-18 | See Tai Sandi Chief Development Officer | Sale | −386 | $9.27 | $4K | 65,476 |
| 2025-10-17 | See Tai Sandi Chief Development Officer | Sale | −3,844 | $8.94 | $34K | 65,906 |
| 2025-10-17 | See Tai Sandi Chief Development Officer | Sale | −44 | $9.56 | $421 | 65,862 |
| 2025-10-15 | See Tai Sandi Chief Development Officer | Grant or award | +10,890 | 69,750 | ||
| 2025-08-18 | See Tai Sandi Chief Development Officer | Sale | −382 | $4.67 | $2K | 58,860 |
| 2025-05-16 | See Tai Sandi Chief Development Officer | Sale | −367 | $2.77 | $1K | 59,242 |
| 2025-03-14 | See Tai Sandi Chief Development Officer | Grant or award | +5,720 | $2.61 | $15K | 59,609 |
| 2025-02-19 | See Tai Sandi Chief Development Officer | Sale | −1,486 | $4.41 | $7K | 53,889 |
| 2025-01-07 | See Tai Sandi Chief Development Officer | Grant or award | +38,750 | 55,375 | ||
| 2025-01-07 | See Tai Sandi Chief Development Officer | Grant or award · Stock Option (right to buy) | +77,500 | 77,500 |
Page 1 of 1 · 10 trades